Detection, Diagnosis and Treatment of Pseudobulbar Affect
CLICK to ENLARGE FLYER
THU, 3 NOV // 7:00 AM – 8:00 AM
Hilton Chicago, 720 S. Michigan Ave, Chicago, IL
Is it depression or something else? Pseudobulbar Affect (PBA) occurs secondary to a variety of otherwise unrelated
neurologic conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying.
Sign-up today and plan to attend this informative, non-CE, therapeutic update sponsored by ACRM exhibitor, Avanir Pharmaceuticals, Inc. Breakfast will be provided.
OBJECTIVES:
- Provide an overview of pseudobulbar affect (PBA), including associated neurologic disorders, prevalence, pathophysiology, and diagnostic challenges
- Review clinical patient cases and explore diagnostic and treatment considerations
- Introduce an FDA-approved treatment option for PBA and discuss
the clinical data supporting its use
WHO SHOULD ATTEND?
Registered attendees of the ACRM 93rd Annual Conference who are healthcare providers serving populations with a diagnosis of brain injury, stroke and/or neurologic conditions such as Alzheimer’s disease and other dementias, Parkinson’s disease or multiple sclerosis.
SPACE IS LIMITED. SIGN-UP TODAY!
Attendees who wish to participate in this sponsored breakfast lecture may RSVP by emailing Sarah Barrah, ACRM Member Services Manager. Please don’t delay. Space is limited.
Go to Conference Website >>
